SCHEMBL5452004

SCHEMBL5452004

Cn1c(N)nc2cccc(-c3ccc(-c4ccccc4)cc3)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.55
KDM4E B2RXH2 3/20 0.47
DHODH Q02127 1/20 0.46
BACE1 P56817 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 2/20 0.39
GAA P10253 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
TLR8 Q9NR97 1/20 0.38
MET P08581 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11056464 0.74 ALDH1A1 (0.46) KDM4EDHODHCYP1A2CYP3A4CYP2D6
SCHEMBL5457312 0.73 PRMT5 (0.66) PRMT5KDM4ECYP1A2CYP2D6ALDH1A1
SCHEMBL5104145 0.71 PRMT5 (1.00) PRMT5KDM4EGAATP53TLR8
SCHEMBL5448072 0.71 PRMT5 (0.64) PRMT5KDM4EBACE1CYP1A2CYP2D6
SCHEMBL5025943 0.71 PRMT5 (0.58) PRMT5KDM4ECYP1A2CYP2D6TLR8
SCHEMBL15540772 0.71 PIK3CA (0.49) KDM4EBACE1CYP1A2CYP3A4CYP2D6
SCHEMBL34467155 0.71 HRH4 (0.44) KDM4EBACE1CYP1A2CYP3A4CYP2D6
SCHEMBL21555506 0.71 HRH4 (0.44) KDM4EBACE1CYP1A2CYP3A4CYP2D6
SCHEMBL5459067 0.69 PRMT5 (0.60) PRMT5KDM4ECYP3A4ALDH1A1HSD17B10
SCHEMBL5455913 0.69 PRMT5 (0.60) PRMT5KDM4ECYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 PRMT5 2145/4885KDM4E 2704/4885DHODH 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.